You are here: Home » Markets » News
Domestic MFs line up chip funds as stocks soar
Street signs: New demat accounts rise, F&O stock list swells, and more
Business Standard

Brokerages are betting on pharma stocks with India focus: Analysts

While domestic growth is pegged at double digits, recovery in the US may take a couple of quarters

Topics
Indian market | Stock Market | Pharma stocks

Ram Prasad Sahu 



Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
Representative image

The only sectoral index that managed to end in the green despite the mayhem on Friday was the BSE Healthcare — with a gain of 1.2 per cent. Investors are betting on the health-care space to be the beneficiary following a worldwide alert on the new Covid variant, Omicron. Within the pharmaceutical space, are betting on domestic-oriented pharma companies as compared to larger generic players, which are witnessing multiple headwinds in the US market.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sun, November 28 2021. 22:59 IST

RECOMMENDED FOR YOU

.